Evidence map›Paper›PMID 29259211›Full record

ArticleScientific reports2017

GSTO1-1 plays a pro-inflammatory role in models of inflammation, colitis and obesity.

Deepthi Menon, Ashlee Innes, Aaron J Oakley, Jane E Dahlstrom, Lora M Jensen, Anne Brüstle, Padmaja Tummala, Melissa Rooke, Marco G Casarotto, Jonathan B Baell and 9 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed, 1 pooled it
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 1 synthesis or guideline pooled it, 64 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Tissue-Specific Expression of Glutathione-S-Transferase Isoforms in Myelomeningocele: An Immunohistochemical Study.Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery · 2025
    Article
  5. Article
  6. The Effect of Circulating Proteins and Their Role in Mediating Adiposity's Effect on Endometrial Cancer Risk: Mendelian Randomization and Colocalization Analyses.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2025
    Article
  7. Article
  8. Regulatory Effects of 198-bp Structural Variants in theInternational journal of molecular sciences · 2024
    Article
  9. Article
  10. Regulation of GlutathioneInternational journal of molecular sciences · 2024
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. TheMedicina (Kaunas, Lithuania) · 2023
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 8 institutions in 4 countries.

Deepthi MenonJohn Curtin School of Medical Research, Australian National University, Canberra, ACT 2600, Australia.
Ashlee InnesJohn Curtin School of Medical Research, Australian National University, Canberra, ACT 2600, Australia.
Aaron J OakleySchool of Chemistry, University of Wollongong, Wollongong, NSW, 2522, Australia.
Jane E DahlstromACT Pathology and ANU Medical School, The Canberra Hospital, Garran, ACT 2605, Australia.
Lora M JensenJohn Curtin School of Medical Research, Australian National University, Canberra, ACT 2600, Australia.
Anne BrüstleJohn Curtin School of Medical Research, Australian National University, Canberra, ACT 2600, Australia.
Padmaja TummalaJohn Curtin School of Medical Research, Australian National University, Canberra, ACT 2600, Australia.
Melissa RookeJohn Curtin School of Medical Research, Australian National University, Canberra, ACT 2600, Australia.
Marco G CasarottoJohn Curtin School of Medical Research, Australian National University, Canberra, ACT 2600, Australia.
Jonathan B BaellMonash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria, 3052, Australia.ORCID 0000-0003-2114-8242
Nghi NguyenMonash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria, 3052, Australia.ORCID 0000-0001-7496-7300
Yiyue XieMonash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria, 3052, Australia.
Matthew CuellarInstitute for Therapeutics Discovery and Development, University of Minnesota, Minneapolis, MN, USA.ORCID 0000-0003-3365-2120
Jessica StrasserInstitute for Therapeutics Discovery and Development, University of Minnesota, Minneapolis, MN, USA.ORCID 0000-0002-6454-4299
Jayme L DahlinDepartment of Pathology, Brigham and Women's Hospital, Boston, MA, USA.
Michael A WaltersInstitute for Therapeutics Discovery and Development, University of Minnesota, Minneapolis, MN, USA.ORCID 0000-0001-5650-9277
Gaetan BurgioJohn Curtin School of Medical Research, Australian National University, Canberra, ACT 2600, Australia.ORCID 0000-0002-7434-926X
Luke A J O'NeillSchool of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin 2, Ireland.
Philip G BoardJohn Curtin School of Medical Research, Australian National University, Canberra, ACT 2600, Australia. Philip.Board@anu.edu.au.ORCID 0000-0003-2752-0332
Australian National University · AUUniversity of Minnesota · USMonash University · AUBrigham and Women's Hospital · USCanberra Hospital · AUNanjing Tech University · CNTrinity College Dublin · IEUniversity of Wollongong · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Glutathione transferase Omega 1 (GSTO1-1) is an atypical GST reported to play a pro-inflammatory role in response to LPS. Here we show that genetic knockout of Gsto1 alters the response of mice to three distinct inflammatory disease models. GSTO1-1 deficiency ameliorates the inflammatory response stimulated by LPS and attenuates the inflammatory impact of a high fat diet on glucose tolerance and insulin resistance. In contrast, GSTO1-1 deficient mice show a more severe inflammatory response and increased escape of bacteria from the colon into the lymphatic system in a dextran sodium sulfate mediated model of inflammatory bowel disease. These responses are similar to those of TLR4 and MyD88 deficient mice in these models and confirm that GSTO1-1 is critical for a TLR4-like pro-inflammatory response in vivo. In wild-type mice, we show that a small molecule inhibitor that covalently binds in the active site of GSTO1-1 can be used to ameliorate the inflammatory response to LPS. Our findings demonstrate the potential therapeutic utility of GSTO1-1 inhibitors in the modulation of inflammation and suggest their possible application in the treatment of a range of inflammatory conditions.

Indexed as

AnimalsCarrier ProteinsColitisGlutathione TransferaseInflammationMaleMiceMice, Inbred C57BLMyeloid Differentiation Factor 88ObesitySmall Molecule LibrariesToll-Like Receptor 4Carrier ProteinsGlutathione TransferaseGsto1 protein, mouseMyeloid Differentiation Factor 88Small Molecule LibrariesToll-Like Receptor 4

Identifiers

PMID29259211
PMCPMC5736720
OpenAlexW2772018329

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.